Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT in active Crohn's disease
NCT04970446Phase 2Recruiting
- Sponsor
- St Vincent's Hospital Melbourne
- Start
- May 2022
- Primary completion
- Apr 2025
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic fecal microbiota in Crohn's disease, sponsored by St Vincent's Hospital Melbourne. Started May 2022; status: recruiting.
02
Drugs
allogeneic fecal microbiota
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT04970446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04970446.